MedPath

Investigation of the effects of 4-week ingestion of the development code GIC food

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000039217
Lead Sponsor
Kao Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

-Subjects taking GIC (development code) analog on a daily basis. -Subjects with allergy or hypersensitivity to GIC (development code). -Subjects with systemic illness. -Subjects with a anamnesis of seizures based on nervous system disorders. -Subjects who regularly take medicine. -Subjects who has changed body weight more than +/- 3kg during 3 months before the test. -Subjects with skin diseases on their face. -Subjects undergoing beauty treatment (chemical peeling, laser treatment, etc.). -Subjects who do not agree not to change their usual cosmetics during the test period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of the effects of 4-week intake of GIC (development code) food on lipid and glucose metabolism, skin condition, body temperature, and so on.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath